0002136449 2026-05-26 2026-05-26 0002136449 dei:BusinessContactMember 2026-05-26 2026-05-26 0002136449 CSCA:PrivateUnitsMember CSCA:CrestoneStrategicCapitalLimitedMember 2026-05-26 2026-05-26 0002136449 CSCA:OverAllotmentOptionMember CSCA:CrestoneStrategicCapitalLimitedMember 2026-05-26 2026-05-26 0002136449 spac:FounderSharesMember CSCA:CrestoneStrategicCapitalLimitedMember 2026-05-26 2026-05-26 0002136449 CSCA:OrdinarySharesSubjectToSurrenderAndForfeitureMember CSCA:CrestoneStrategicCapitalLimitedMember 2026-05-26 2026-05-26 0002136449 CSCA:OrdinarySharesMember CSCA:CrestoneStrategicCapitalLimitedMember 2026-05-26 2026-05-26 0002136449 2026-04-30 2026-04-30 0002136449 spac:OverAllotmentOptionExercisedMember 2026-04-30 2026-04-30 0002136449 spac:OverAllotmentOptionExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 spac:OverAllotmentOptionExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 spac:OverAllotmentOptionExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 spac:OverAllotmentOptionExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 spac:OverAllotmentOptionNotExercisedMember 2026-04-30 2026-04-30 0002136449 spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:CrestoneStrategicCapitalLimitedMember 2026-05-26 2026-05-26 0002136449 spac:OverAllotmentOptionNotExercisedMember spac:NoRedemptionMember 2026-04-30 2026-04-30 0002136449 spac:OverAllotmentOptionExercisedMember spac:NoRedemptionMember 2026-04-30 2026-04-30 0002136449 CSCA:InitialShareholdersMember 2026-04-30 2026-04-30 0002136449 CSCA:PrivatePlacementSharesMember 2026-04-30 2026-04-30 0002136449 CSCA:PublicShareholdersMember 2026-04-30 2026-04-30 0002136449 CSCA:OrdinarySharesOutstandingPriorToThisOfferingMember CSCA:WithoutOverAllotmentMember spac:NoRedemptionMember 2026-04-30 2026-04-30 0002136449 CSCA:OrdinarySharesOutstandingPriorToThisOfferingMember CSCA:WithOverAllotmentMember spac:NoRedemptionMember 2026-04-30 2026-04-30 0002136449 CSCA:OrdinarySharesOutstandingPriorToThisOfferingMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:OrdinarySharesOutstandingPriorToThisOfferingMember CSCA:WithOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:OrdinarySharesOutstandingPriorToThisOfferingMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:OrdinarySharesOutstandingPriorToThisOfferingMember CSCA:WithOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:OrdinarySharesOutstandingPriorToThisOfferingMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:OrdinarySharesOutstandingPriorToThisOfferingMember CSCA:WithOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:OrdinarySharesOutstandingPriorToThisOfferingMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:OrdinarySharesOutstandingPriorToThisOfferingMember CSCA:WithOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:OrdinarySharesForfeitedIfOverallotmentIsNotExercisedMember CSCA:WithoutOverAllotmentMember spac:NoRedemptionMember 2026-04-30 2026-04-30 0002136449 CSCA:OrdinarySharesForfeitedIfOverallotmentIsNotExercisedMember CSCA:WithOverAllotmentMember spac:NoRedemptionMember 2026-04-30 2026-04-30 0002136449 CSCA:OrdinarySharesForfeitedIfOverallotmentIsNotExercisedMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:OrdinarySharesForfeitedIfOverallotmentIsNotExercisedMember CSCA:WithOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:OrdinarySharesForfeitedIfOverallotmentIsNotExercisedMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:OrdinarySharesForfeitedIfOverallotmentIsNotExercisedMember CSCA:WithOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:OrdinarySharesForfeitedIfOverallotmentIsNotExercisedMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:OrdinarySharesForfeitedIfOverallotmentIsNotExercisedMember CSCA:WithOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:OrdinarySharesForfeitedIfOverallotmentIsNotExercisedMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:OrdinarySharesForfeitedIfOverallotmentIsNotExercisedMember CSCA:WithOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:OrdinarySharesOfferedAndSaleOfPrivatePlacementSharesMember CSCA:WithoutOverAllotmentMember spac:NoRedemptionMember 2026-04-30 2026-04-30 0002136449 CSCA:OrdinarySharesOfferedAndSaleOfPrivatePlacementSharesMember CSCA:WithOverAllotmentMember spac:NoRedemptionMember 2026-04-30 2026-04-30 0002136449 CSCA:OrdinarySharesOfferedAndSaleOfPrivatePlacementSharesMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:OrdinarySharesOfferedAndSaleOfPrivatePlacementSharesMember CSCA:WithOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:OrdinarySharesOfferedAndSaleOfPrivatePlacementSharesMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:OrdinarySharesOfferedAndSaleOfPrivatePlacementSharesMember CSCA:WithOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:OrdinarySharesOfferedAndSaleOfPrivatePlacementSharesMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:OrdinarySharesOfferedAndSaleOfPrivatePlacementSharesMember CSCA:WithOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:OrdinarySharesOfferedAndSaleOfPrivatePlacementSharesMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:OrdinarySharesOfferedAndSaleOfPrivatePlacementSharesMember CSCA:WithOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:SharesSubjectToRedemptionMember CSCA:WithoutOverAllotmentMember spac:NoRedemptionMember 2026-04-30 2026-04-30 0002136449 CSCA:SharesSubjectToRedemptionMember CSCA:WithOverAllotmentMember spac:NoRedemptionMember 2026-04-30 2026-04-30 0002136449 CSCA:SharesSubjectToRedemptionMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:SharesSubjectToRedemptionMember CSCA:WithOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:SharesSubjectToRedemptionMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:SharesSubjectToRedemptionMember CSCA:WithOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:SharesSubjectToRedemptionMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:SharesSubjectToRedemptionMember CSCA:WithOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:SharesSubjectToRedemptionMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:SharesSubjectToRedemptionMember CSCA:WithOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:WithoutOverAllotmentMember spac:NoRedemptionMember 2026-04-30 2026-04-30 0002136449 CSCA:WithOverAllotmentMember spac:NoRedemptionMember 2026-04-30 2026-04-30 0002136449 CSCA:WithoutOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:WithOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:WithoutOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:WithOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:WithoutOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:WithOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:WithoutOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:WithOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:NetProceedsFromThisOfferingAndTheSaleOfThePrivatePlacementSharesMember CSCA:WithoutOverAllotmentMember spac:NoRedemptionMember 2026-04-30 2026-04-30 0002136449 CSCA:NetProceedsFromThisOfferingAndTheSaleOfThePrivatePlacementSharesMember CSCA:WithOverAllotmentMember spac:NoRedemptionMember 2026-04-30 2026-04-30 0002136449 CSCA:NetProceedsFromThisOfferingAndTheSaleOfThePrivatePlacementSharesMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:NetProceedsFromThisOfferingAndTheSaleOfThePrivatePlacementSharesMember CSCA:WithOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:NetProceedsFromThisOfferingAndTheSaleOfThePrivatePlacementSharesMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:NetProceedsFromThisOfferingAndTheSaleOfThePrivatePlacementSharesMember CSCA:WithOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:NetProceedsFromThisOfferingAndTheSaleOfThePrivatePlacementSharesMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:NetProceedsFromThisOfferingAndTheSaleOfThePrivatePlacementSharesMember CSCA:WithOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:NetProceedsFromThisOfferingAndTheSaleOfThePrivatePlacementSharesMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:NetProceedsFromThisOfferingAndTheSaleOfThePrivatePlacementSharesMember CSCA:WithOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:OfferingCostsPaidInAdvanceExcludedFromTangibleBookValueMember CSCA:WithoutOverAllotmentMember spac:NoRedemptionMember 2026-04-30 2026-04-30 0002136449 CSCA:OfferingCostsPaidInAdvanceExcludedFromTangibleBookValueMember CSCA:WithOverAllotmentMember spac:NoRedemptionMember 2026-04-30 2026-04-30 0002136449 CSCA:OfferingCostsPaidInAdvanceExcludedFromTangibleBookValueMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:OfferingCostsPaidInAdvanceExcludedFromTangibleBookValueMember CSCA:WithOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:OfferingCostsPaidInAdvanceExcludedFromTangibleBookValueMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:OfferingCostsPaidInAdvanceExcludedFromTangibleBookValueMember CSCA:WithOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:OfferingCostsPaidInAdvanceExcludedFromTangibleBookValueMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:OfferingCostsPaidInAdvanceExcludedFromTangibleBookValueMember CSCA:WithOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:OfferingCostsPaidInAdvanceExcludedFromTangibleBookValueMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:OfferingCostsPaidInAdvanceExcludedFromTangibleBookValueMember CSCA:WithOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:DeferredUnderwritingFeesMember CSCA:WithoutOverAllotmentMember spac:NoRedemptionMember 2026-04-30 2026-04-30 0002136449 CSCA:DeferredUnderwritingFeesMember CSCA:WithOverAllotmentMember spac:NoRedemptionMember 2026-04-30 2026-04-30 0002136449 CSCA:DeferredUnderwritingFeesMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:DeferredUnderwritingFeesMember CSCA:WithOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:DeferredUnderwritingFeesMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:DeferredUnderwritingFeesMember CSCA:WithOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:DeferredUnderwritingFeesMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:DeferredUnderwritingFeesMember CSCA:WithOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:DeferredUnderwritingFeesMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:DeferredUnderwritingFeesMember CSCA:WithOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 spac:OverallotmentLiabilityMember CSCA:WithoutOverAllotmentMember spac:NoRedemptionMember 2026-04-30 2026-04-30 0002136449 spac:OverallotmentLiabilityMember CSCA:WithOverAllotmentMember spac:NoRedemptionMember 2026-04-30 2026-04-30 0002136449 spac:OverallotmentLiabilityMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 spac:OverallotmentLiabilityMember CSCA:WithOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 spac:OverallotmentLiabilityMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 spac:OverallotmentLiabilityMember CSCA:WithOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 spac:OverallotmentLiabilityMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 spac:OverallotmentLiabilityMember CSCA:WithOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 spac:OverallotmentLiabilityMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 spac:OverallotmentLiabilityMember CSCA:WithOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:ProceedsFromFounderSharesMember CSCA:WithoutOverAllotmentMember spac:NoRedemptionMember 2026-04-30 2026-04-30 0002136449 CSCA:ProceedsFromFounderSharesMember CSCA:WithOverAllotmentMember spac:NoRedemptionMember 2026-04-30 2026-04-30 0002136449 CSCA:ProceedsFromFounderSharesMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:ProceedsFromFounderSharesMember CSCA:WithOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:ProceedsFromFounderSharesMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:ProceedsFromFounderSharesMember CSCA:WithOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:ProceedsFromFounderSharesMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:ProceedsFromFounderSharesMember CSCA:WithOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:ProceedsFromFounderSharesMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:ProceedsFromFounderSharesMember CSCA:WithOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:AmountPaidForRedemptionsMember CSCA:WithoutOverAllotmentMember spac:NoRedemptionMember 2026-04-30 2026-04-30 0002136449 CSCA:AmountPaidForRedemptionsMember CSCA:WithOverAllotmentMember spac:NoRedemptionMember 2026-04-30 2026-04-30 0002136449 CSCA:AmountPaidForRedemptionsMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:AmountPaidForRedemptionsMember CSCA:WithOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:AmountPaidForRedemptionsMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:AmountPaidForRedemptionsMember CSCA:WithOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:AmountPaidForRedemptionsMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:AmountPaidForRedemptionsMember CSCA:WithOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:AmountPaidForRedemptionsMember CSCA:WithoutOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 CSCA:AmountPaidForRedemptionsMember CSCA:WithOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember 2026-04-30 2026-04-30 0002136449 spac:FounderSharesMember 2026-05-26 2026-05-26 0002136449 CSCA:PrivatePlacementSharesMember 2026-05-26 2026-05-26 iso4217:USD shares iso4217:USD shares false 0002136449 Limited Liability Company S-1 Crestone Strategic Capital Acquisition Corporation E9 211 East 43rd Street FL 7-100 New York NY 10017 (332) 296-0822 Cogency Global Inc. 122 East 42nd Street 18th Floor New York NY 10168 (212) 947-7200 Non-accelerated Filer true true false true true We will have up to 15 months to consummate an initial business combination from the closing of this offering. We refer to the time period we have to complete an initial business combination as the “completion window.” <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyLCBTUEFDIFJlZ2lzdGVyZWQgT2ZmZXJpbmdzAA__" id="xdx_90A_espac--DeSpacConsummationTimeframeExtensionSecurityHoldersVotingOrRedemptionRightsFlag_dbT_c20260526__20260526_zv8Bc4eMAy9h">We may seek shareholder approval to amend our amended and restated memorandum and articles of association to extend the date by which we must consummate our initial business combination. There is no limit on the number of extensions that we may seek. P15M true true true 314250 345188 10.00 3142500 3451875 3354167 25000 437500 true The following table illustrates the difference between the public offering price per share and our net tangible book value per share (NTBV), as adjusted to give effect to this offering and assuming the redemption of our public shares at varying levels and the exercise in full and no exercise of the over-allotment option. See the sections titled “Prospectus Summary - Dilution” and “Dilution” for more information. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="34" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of April 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Offering Price of $10.00 per Share</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">25% of Maximum Redemption</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">50% of Maximum Redemption</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">75% of Maximum Redemption</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">Maximum Redemption</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">NTBV</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">NTBV</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Difference between NTBV and Offering Price</td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">NTBV</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Difference between NTBV and Offering Price</td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">NTBV</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Difference between NTBV and Offering Price</td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">NTBV</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Difference between NTBV and Offering Price</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td colspan="35" style="padding-bottom: 1pt; text-align: center">Assuming Full Exercise of Over-Allotment Option</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 1%; text-align: left">$</td><td style="width: 7%; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_904_espac--NetTangibleBookValueAdjustedPerShare_pid_c20260430__20260430__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember_zRNEWWl0Y3O7">6.80</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 7%; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_90B_espac--NetTangibleBookValueAdjustedPerShare_pid_c20260430__20260430__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt25PercentOfMaximumMember_zLqyXeiTXuQ2">6.23</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGMpIERpbHV0aW9uAA__" id="xdx_90F_espac--DifferenceBetweenTheOfferingPriceAndTheAdjustedNetTangibleBookValue1PerShare_pid_c20260430__20260430__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt25PercentOfMaximumMember_zOtcTQFgtekb">3.77</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 8%; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_90D_espac--NetTangibleBookValueAdjustedPerShare_pid_c20260430__20260430__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt50PercentOfMaximumMember_ziMnlACzyw5d">5.34</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGMpIERpbHV0aW9uAA__" id="xdx_903_espac--DifferenceBetweenTheOfferingPriceAndTheAdjustedNetTangibleBookValue1PerShare_pid_c20260430__20260430__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt50PercentOfMaximumMember_ziwQS0pPrx89">4.65</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 8%; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_901_espac--NetTangibleBookValueAdjustedPerShare_pid_c20260430__20260430__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt75PercentOfMaximumMember_z8YZ1XJKiMVe">3.82</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGMpIERpbHV0aW9uAA__" id="xdx_908_espac--DifferenceBetweenTheOfferingPriceAndTheAdjustedNetTangibleBookValue1PerShare_pid_c20260430__20260430__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt75PercentOfMaximumMember_zsb6nP0pEzg1">6.18</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 8%; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_907_espac--NetTangibleBookValueAdjustedPerShare_pid_c20260430__20260430__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt100PercentOfMaximumMember_zYjQKKt79Ql9">0.51</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGMpIERpbHV0aW9uAA__" id="xdx_906_espac--DifferenceBetweenTheOfferingPriceAndTheAdjustedNetTangibleBookValue1PerShare_pid_c20260430__20260430__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt100PercentOfMaximumMember_zQSXKlR3Jg2c">9.49</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td colspan="35" style="text-align: left">Assuming No Exercise of Over-Allotment Option </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_907_espac--NetTangibleBookValueAdjustedPerShare_pid_c20260430__20260430__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember_zd3qkcEAfrf5">6.80</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_900_espac--NetTangibleBookValueAdjustedPerShare_pid_c20260430__20260430__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt25PercentOfMaximumMember_z73YIzaOzJtl">6.22</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGMpIERpbHV0aW9uAA__" id="xdx_908_espac--DifferenceBetweenTheOfferingPriceAndTheAdjustedNetTangibleBookValue1PerShare_pid_c20260430__20260430__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt25PercentOfMaximumMember_zdbL8Zmai8Hl">3.78</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_903_espac--NetTangibleBookValueAdjustedPerShare_pid_c20260430__20260430__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt50PercentOfMaximumMember_zcCOCdX2m714">5.34</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGMpIERpbHV0aW9uAA__" id="xdx_90A_espac--DifferenceBetweenTheOfferingPriceAndTheAdjustedNetTangibleBookValue1PerShare_pid_c20260430__20260430__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt50PercentOfMaximumMember_zKl0Tx3VdyG">4.65</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_904_espac--NetTangibleBookValueAdjustedPerShare_pid_c20260430__20260430__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt75PercentOfMaximumMember_zHyQi1JeI3z6">3.82</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGMpIERpbHV0aW9uAA__" id="xdx_906_espac--DifferenceBetweenTheOfferingPriceAndTheAdjustedNetTangibleBookValue1PerShare_pid_c20260430__20260430__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt75PercentOfMaximumMember_zCKlpfwFgmHc">6.18</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_90D_espac--NetTangibleBookValueAdjustedPerShare_pid_c20260430__20260430__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt100PercentOfMaximumMember_zg7Nf7JBn7N5">0.53</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGMpIERpbHV0aW9uAA__" id="xdx_905_espac--DifferenceBetweenTheOfferingPriceAndTheAdjustedNetTangibleBookValue1PerShare_pid_c20260430__20260430__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt100PercentOfMaximumMember_z1DzNMZCqajg">9.47</td><td style="text-align: left"> </td></tr> </table> 10.00 6.80 6.23 3.77 5.34 4.65 3.82 6.18 0.51 9.49 6.80 6.22 3.78 5.34 4.65 3.82 6.18 0.53 9.47 true Crestone Strategic Capital Limited business company Mr. Shuya Iwamoto The following table sets forth the payments to be received by our sponsor and its affiliates from us prior to or in connection with the completion of our initial business combination and the securities issued and to be issued by us to our sponsor or its affiliates: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%">Entity/Individual</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 2%"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: center">Amount of Compensation to be Received or Securities Issued or to be Issued</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 2%"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: center">Consideration Paid or to be Paid</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td rowspan="2" style="font: 10pt Times New Roman, Times, Serif">Crestone Strategic Capital Limited</td> <td rowspan="2" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDMpIEZvcmVwYXJ0LCBTcG9uc29yIENvbXBlbnNhdGlvbgA_" id="xdx_90E_espac--SecuritiesIssuedOrToBeIssuedShares_c20260526__20260526__spac--SpacSponsorAffiliateOrPromoterAxis__custom--CrestoneStrategicCapitalLimitedMember__spac--CompensationNatureAxis__custom--OrdinarySharesMember_fKDEp_zAbRnQpysC5c">2,916,667 ordinary shares (1) </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif">$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDMpIEZvcmVwYXJ0LCBTcG9uc29yIENvbXBlbnNhdGlvbgA_" id="xdx_909_espac--PricePaidOrToBePaidForSecuritiesTotalAmount_c20260526__20260526__spac--SpacSponsorAffiliateOrPromoterAxis__custom--CrestoneStrategicCapitalLimitedMember__spac--CompensationNatureAxis__custom--OrdinarySharesMember_zNcWd06b2Re4">25,000</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDMpIEZvcmVwYXJ0LCBTcG9uc29yIENvbXBlbnNhdGlvbgA_" id="xdx_900_espac--SecuritiesIssuedOrToBeIssuedShares_c20260526__20260526__spac--SpacSponsorAffiliateOrPromoterAxis__custom--CrestoneStrategicCapitalLimitedMember__spac--CompensationNatureAxis__custom--PrivateUnitsMember_fKDEp_zH1bVjkbPX1k">314,250 private placement shares (1)</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif">$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDMpIEZvcmVwYXJ0LCBTcG9uc29yIENvbXBlbnNhdGlvbgA_" id="xdx_908_espac--PricePaidOrToBePaidForSecuritiesTotalAmount_c20260526__20260526__spac--SpacSponsorAffiliateOrPromoterAxis__custom--CrestoneStrategicCapitalLimitedMember__spac--CompensationNatureAxis__custom--PrivateUnitsMember_zP2lnMD4n5Qb">3,142,500 </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Up to $600,000</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Repayment of loans made to us by our sponsor to cover offering-related and organizational expenses and to finance transaction costs in connection with an intended initial business combination. </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGIpKDYpIFByb3NwZWN0dXMgU3VtbWFyeSwgU3BvbnNvciBDb21wZW5zYXRpb24A" id="xdx_90F_espac--PricePaidOrToBePaidForSecuritiesTotalAmount_c20260526__20260526__spac--SpacSponsorAffiliateOrPromoterAxis__custom--CrestoneStrategicCapitalLimitedMember_zDgBNXxExs8h" title="Price Paid or to be Paid for Securities, Total Amount">10,000 per month</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Office space, administrative and support services </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Up to $1,500,000 in working capital loans may be convertible into private placement shares at a price of $10.00 per share</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Working capital loans to finance transaction costs in connection with an intended initial business combination. </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGIpKDYpIFByb3NwZWN0dXMgU3VtbWFyeSwgU3BvbnNvciBDb21wZW5zYXRpb24A" id="xdx_980_espac--SpacSponsorNatureOfReimbursement_c20260526__20260526__spac--SpacSponsorAffiliateOrPromoterAxis__custom--CrestoneStrategicCapitalLimitedMember_zj1sTQ2EPcX3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify" title="SPAC Sponsor, Nature of Reimbursement">Reimbursement for any out-of-pocket expenses related to identifying, investigating and completing an initial business combination</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Services in connection with identifying, investigating and completing an initial business combination.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">(1)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Assumes no exercise of the over-allotment option and the full surrender and forfeiture of 437,500 shares that are subject to surrender and forfeiture by certain of our initial shareholders depending on the extent to which the underwriters’ over-allotment option is exercised. If we increase or decrease the size of this offering, we will effect a share dividend or share contribution back to capital or other appropriate mechanism, as applicable, with respect to the founder shares immediately prior to the consummation of this offering in such amount as to maintain the number of founder shares at 28% of our issued and outstanding ordinary shares upon the consummation of this offering (not including the private placement shares and assuming the sponsor does not purchase shares in this offering), with any such change in the number of founder shares to be allocated to our sponsor.</td></tr> </table> 2916667 25000 314250 3142500 10000 Reimbursement for any out-of-pocket expenses related to identifying, investigating and completing an initial business combination 7,500,000 shares (or 8,625,000 shares if the underwriters’ over-allotment option is exercised in full), at $10.00 per share. Our officers and directors may owe competing duties to other enterprises, and opportunities presented to them may not be presented to us as a result of such conflicts. Also, each of our officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such officers and directors was included by a target business as a condition to any agreement with respect to our initial business combination.Our initial shareholders are not prohibited from sponsoring, investing in or otherwise becoming involved with, any other blank check companies (including special purpose acquisition companies similar to our company), including in connection with their initial business combinations, prior to us completing our initial business combination. Potential investors should also be aware of certain potential conflicts of interest as further described in See “Proposed Business - Our Acquisition Process” and “Management - Conflicts of Interest.”If any of our directors or officers become aware of a business combination opportunity which is suitable for another entity to whom they owe fiduciary or contractual duties, he or she may need to honor his or her fiduciary or contractual obligations to present such business combination opportunity to such entity, and only present it to us if such entity rejects the opportunity, subject to their fiduciary duties under Cayman Islands law. Our amended and restated memorandum and articles of association provide that, to the fullest extent permitted by applicable law: (i) no individual serving as a director or an officer shall have any duty, except and to the extent expressly assumed by contract, to refrain from engaging directly or indirectly in the same or similar business activities or lines of business as us; and (ii) we renounce any interest or expectancy in, or in being offered an opportunity to participate in, any potential transaction or matter which may be a corporate opportunity for any director or officer, on the one hand, and us, on the other. See “Risk Factors - Risks Related to our Sponsor, Management Team, and Their Respective Affiliates - Certain of our initial shareholders, including certain of our directors and officers, are now, and all of them may become, affiliated with entities engaged in business activities similar to those intended to be conducted by us and, accordingly, may have conflicts of interest in determining to which entity a particular business opportunity should be presented.”We are not prohibited from pursuing an initial business combination with a company that is affiliated with our initial shareholders; accordingly, such affiliated person(s) may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination as such affiliated person(s) would have interests different from our public shareholders and would likely not receive any financial benefit unless we consummated such business combination. In the event we seek to complete an initial business combination with a target that is affiliated with our initial shareholders, we, or a committee of independent and disinterested directors, may engage independent advisors to assist with the evaluation and will obtain an opinion from an independent investment banking firm or from an independent accounting firm that such business combination is fair to our company from a financial point of view.In addition, our initial shareholders or any of their affiliates may make additional investments in the company in connection with the initial business combination, although our sponsor and its affiliates have no obligation or current intention to do so. If our initial shareholders or any of their affiliates elects to make additional investments, such proposed investments could influence our initial shareholder’s motivation to complete an initial business combination.Prior to this offering, our sponsor paid a nominal aggregate purchase price of $25,000 for the 3,354,167 founder shares, or approximately $0.0075 per share. In addition, our sponsor has committed to purchase an aggregate of 314,250 (or 345,188 if the underwriters’ over-allotment option is exercised in full) private placement shares for a purchase price of $10.00 per share, or $3,142,500, in the aggregate (or $3,451,875 in the aggregate if the underwriters’ over-allotment option is exercised in full). Because the founder shares and private placement shares held by our sponsor and management will be worthless if we do not complete a business combination transaction during the completion window, members of our board of directors may be economically incentivized to consummate an initial business combination with a riskier, weaker-performing or less-established target business than would be the case if our management had paid the same per share price for the founder shares as our public shareholders paid for their public shares.Payment for the reimbursement for any out-of-pocket expenses related to identifying, investigating, negotiating and completing an initial business combination, and repayment of loans which may be made by our sponsor or an affiliate of our sponsor or certain of our officers and directors to finance transaction costs in connection with an intended initial business combination, may not be paid in the event we do not consummate a business combination.In the event our sponsor or members of our management team provide loans to us to finance transaction costs and/or incur expenses on our behalf in connection with an initial business combination, such persons may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination as such loans may not be repaid and/or such expenses may not be reimbursed unless we consummate such business combination.Similarly, if we agree to pay our sponsor or a member of our management team a finder’s fee, advisory fee, consulting fee or success fee in order to effectuate the completion of our initial business combination, such persons may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination as any such fee may not be paid unless we consummate such business combination. The difference between the public offering price per ordinary share, assuming the pro forma net tangible book value per ordinary share after this offering constitutes the dilution to investors in this offering. Net tangible book value (NTBV) per share is determined by dividing our net tangible book value, which is our total tangible assets less total liabilities (including the value of ordinary shares which may be redeemed for cash), by the number of issued and outstanding ordinary shares. The below calculations (A) assume that (i) no ordinary shares are issued to shareholders of a potential business combination target as consideration or issuable by a post-business combination company, for instance under an equity or employee share purchase plan, (ii) no ordinary shares and convertible equity or debt securities are issued in connection with additional financing that we may seek in connection with an initial business combination, (iii) no working capital loans are converted into private placement shares, as further described in this prospectus, and (B) assume the issuance of 7,500,000 ordinary shares (or 8,625,000 ordinary shares if the over-allotment option is exercised in full), 3,354,167 founder shares (up to 437,500 of which are assumed to be surrendered and forfeited in the scenario in which the over-allotment option is not exercised in full) and 314,250 private placement shares (or 345,188 private placement shares if the over-allotment option is exercised in full). 10.00 6.80 6.23 3.77 5.34 4.65 3.82 6.18 0.51 9.49 6.80 6.22 3.78 5.34 4.65 3.82 6.18 0.53 9.47 <p id="xdx_898_espac--SpacAdjustedNetTangibleBookValuePerShareWithSourcesOfDilutionTableTextBlock_dU_zJs8Hu7JFno5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> The following tables illustrate the dilution to the public shareholders on a per-share basis: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">No exercise of over-allotment option</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20260430__20260430__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember__spac--RedemptionLevelAxis__spac--NoRedemptionMember_zLtyDMXoEzP9" style="border-bottom: Black 1pt solid; text-align: center">No Redemption</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20260430__20260430__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt25PercentOfMaximumMember_zvQGGBv1zSqa" style="border-bottom: Black 1pt solid; text-align: center">25% of Maximum Redemptions</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_494_20260430__20260430__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt50PercentOfMaximumMember_zkxlD2hfsYk" style="border-bottom: Black 1pt solid; text-align: center">50% of Maximum Redemptions</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20260430__20260430__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt75PercentOfMaximumMember_z17c9i5wKpFd" style="border-bottom: Black 1pt solid; text-align: center">75% of Maximum Redemptions</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_494_20260430__20260430__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt100PercentOfMaximumMember_zGHu0VFrnZL7" style="border-bottom: Black 1pt solid; text-align: center">Maximum Redemptions</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_403_espac--RegisteredOfferingPrice1PerShare_pid_uUSDPShares_z04iB33RDD0c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%">Public offering price</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10.00</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_espac--NetTangibleBookValuePreTransactionPerShare_pid_zfMvvdVc2svd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net tangible book value before this offering</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.04</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.04</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.04</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.04</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.04</td><td style="text-align: left">)</td></tr> <tr id="xdx_400_espac--NetTangibleBookValueIncreaseFromPublicShareholdersPerShare_pid_uUSDPShares_zevl0Lhr2om4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Increase/(Decrease) attributable to public shareholders</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6.84</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6.26</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5.38</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3.86</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">0.57</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_espac--NetTangibleBookValueAdjustedPerShare_pid_uUSDPShares_zzhs0FUZLnse" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Pro forma net tangible book value after this offering</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6.80</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6.22</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5.34</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3.82</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">0.53</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_400_espac--NetTangibleBookValueAmountOfDilutionPerShare_pid_uUSDPShares_zyMdHck5nbM4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Dilution to public shareholders</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3.20</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3.78</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4.66</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6.18</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9.47</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Percentage of dilution to public shareholders</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">32.00</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">37.80</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">46.60</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">61.80</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">94.70</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Full exercise of over-allotment option</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20260430__20260430__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember__spac--RedemptionLevelAxis__spac--NoRedemptionMember_zBbDhriYqpD2" style="border-bottom: Black 1pt solid; text-align: center">No Redemption</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20260430__20260430__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt25PercentOfMaximumMember_z8rLBt9v51kc" style="border-bottom: Black 1pt solid; text-align: center">25% of Maximum Redemptions</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20260430__20260430__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt50PercentOfMaximumMember_zYNJ17WL7Knl" style="border-bottom: Black 1pt solid; text-align: center">50% of Maximum Redemptions</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20260430__20260430__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt75PercentOfMaximumMember_z4Md97cgL5t8" style="border-bottom: Black 1pt solid; text-align: center">75% of Maximum Redemptions</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20260430__20260430__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt100PercentOfMaximumMember_zQkVtNMZKkTh" style="border-bottom: Black 1pt solid; text-align: center">Maximum Redemptions</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_403_espac--RegisteredOfferingPrice1PerShare_pid_uUSDPShares_ze3nUcfdSaZf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%">Public offering price</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10.00</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_espac--NetTangibleBookValuePreTransactionPerShare_pid_uUSDPShares_zKc0tVTRx2sg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net tangible book value before this offering</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.03</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.03</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.03</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.03</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.03</td><td style="text-align: left">)</td></tr> <tr id="xdx_409_espac--NetTangibleBookValueIncreaseFromPublicShareholdersPerShare_pid_uUSDPShares_zLErcwTRxyOa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Increase/(Decrease) attributable to public shareholders</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6.83</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6.26</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5.38</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3.85</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">0.54</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40C_espac--NetTangibleBookValueAdjustedPerShare_pid_uUSDPShares_zBVqnod2Se08" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Pro forma net tangible book value after this offering</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6.80</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6.23</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5.34</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3.82</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">0.51</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_espac--NetTangibleBookValueAmountOfDilutionPerShare_pid_uUSDPShares_zsYYFsqaVYEa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Dilution to public shareholders</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3.20</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3.77</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4.65</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6.18</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9.49</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Percentage of dilution to public shareholders</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">32.00</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">37.70</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">46.50</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">61.80</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">94.90</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> </table> 10.00 10.00 10.00 10.00 10.00 -0.04 -0.04 -0.04 -0.04 -0.04 6.84 6.26 5.38 3.86 0.57 6.80 6.22 5.34 3.82 0.53 3.20 3.78 4.66 6.18 9.47 10.00 10.00 10.00 10.00 10.00 -0.03 -0.03 -0.03 -0.03 -0.03 6.83 6.26 5.38 3.85 0.54 6.80 6.23 5.34 3.82 0.51 3.20 3.77 4.65 6.18 9.49 <p id="xdx_896_espac--SpacAdjustedNetTangibleBookValuePerShareCalculationAdditionalInformationTextBlock_dU_zgL7GIgLLBM3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> The following table sets forth information with respect to our initial shareholders and the public shareholders: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares Purchased</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total Consideration</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Average Price</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Percentage</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Percentage</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Per Share</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%">Initial Shareholders(1)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">2,916,667</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">27.18</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">25,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">0.03</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span id="xdx_904_espac--NetTangibleBookValueAdjustedPerShare_c20260430__20260430__spac--DilutionSourceAxis__custom--InitialShareholdersMember_fKDEp_zvAhFoViHLnl" title="Net Tangible Book Value, Adjusted, per Share">0.0086</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Private Placement Shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">314,250</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.93</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">3,142,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.02</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_901_espac--NetTangibleBookValueAdjustedPerShare_c20260430__20260430__spac--DilutionSourceAxis__custom--PrivatePlacementSharesMember_zkgQBrOKxyAf" title="Net Tangible Book Value, Adjusted, per Share">10.00</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Public Shareholders</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">69.89</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">75,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">95.95</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90C_espac--NetTangibleBookValueAdjustedPerShare_c20260430__20260430__spac--DilutionSourceAxis__custom--PublicShareholdersMember_zIRtxT69jxJj" title="Net Tangible Book Value, Adjusted, per Share">10.00</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">10,730,917</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">100.00</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">78,167,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">100.00</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">(1)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Assumes the full surrender and forfeiture of 437,500 founder shares and no exercise of the underwriters’ over-allotment option.</td></tr> </table> The pro forma NTBV per share after this offering for each of the redemption scenarios is calculated as follows: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: White"> <td style="display: none; padding-left: 10pt; text-align: left"> </td><td style="display: none"> </td> <td style="display: none; text-align: left"> </td><td id="xdx_495_20260430__20260430__spac--OverAllotmentOptionAxis__custom--WithoutOverAllotmentMember__spac--RedemptionLevelAxis__spac--NoRedemptionMember_zFL3eI1YArAj" style="display: none; text-align: right"> </td><td style="display: none; text-align: left"> </td><td style="display: none"> </td> <td style="display: none; text-align: left"> </td><td id="xdx_491_20260430__20260430__spac--OverAllotmentOptionAxis__custom--WithOverAllotmentMember__spac--RedemptionLevelAxis__spac--NoRedemptionMember_zulYgF9m2o4e" style="display: none; text-align: right"> </td><td style="display: none; text-align: left"> </td><td style="display: none"> </td> <td style="display: none; text-align: left"> </td><td id="xdx_491_20260430__20260430__spac--OverAllotmentOptionAxis__custom--WithoutOverAllotmentMember__spac--RedemptionLevelAxis__spac--RedemptionAt25PercentOfMaximumMember_zf0mY43Diell" style="display: none; text-align: right"> </td><td style="display: none; text-align: left"> </td><td style="display: none"> </td> <td style="display: none; text-align: left"> </td><td id="xdx_49F_20260430__20260430__spac--OverAllotmentOptionAxis__custom--WithOverAllotmentMember__spac--RedemptionLevelAxis__spac--RedemptionAt25PercentOfMaximumMember_z6QI4UCVRs1f" style="display: none; text-align: right"> </td><td style="display: none; text-align: left"> </td><td style="display: none"> </td> <td style="display: none; text-align: left"> </td><td id="xdx_49D_20260430__20260430__spac--OverAllotmentOptionAxis__custom--WithoutOverAllotmentMember__spac--RedemptionLevelAxis__spac--RedemptionAt50PercentOfMaximumMember_zP9w6eo3xjmd" style="display: none; text-align: right"> </td><td style="display: none; text-align: left"> </td><td style="display: none"> </td> <td style="display: none; text-align: left"> </td><td id="xdx_499_20260430__20260430__spac--OverAllotmentOptionAxis__custom--WithOverAllotmentMember__spac--RedemptionLevelAxis__spac--RedemptionAt50PercentOfMaximumMember_zO5H368eAAr1" style="display: none; text-align: right"> </td><td style="display: none; text-align: left"> </td><td style="display: none"> </td> <td style="display: none; text-align: left"> </td><td id="xdx_493_20260430__20260430__spac--OverAllotmentOptionAxis__custom--WithoutOverAllotmentMember__spac--RedemptionLevelAxis__spac--RedemptionAt75PercentOfMaximumMember_zm6HHnbDfFNi" style="display: none; text-align: right"> </td><td style="display: none; text-align: left"> </td><td style="display: none"> </td> <td style="display: none; text-align: left"> </td><td id="xdx_49A_20260430__20260430__spac--OverAllotmentOptionAxis__custom--WithOverAllotmentMember__spac--RedemptionLevelAxis__spac--RedemptionAt75PercentOfMaximumMember_z4UvWiFEzGZ4" style="display: none; text-align: right"> </td><td style="display: none; text-align: left"> </td><td style="display: none"> </td> <td style="display: none; text-align: left"> </td><td id="xdx_498_20260430__20260430__spac--OverAllotmentOptionAxis__custom--WithoutOverAllotmentMember__spac--RedemptionLevelAxis__spac--RedemptionAt100PercentOfMaximumMember_zc2wd37RXaD9" style="display: none; text-align: right"> </td><td style="display: none; text-align: left"> </td><td style="display: none"> </td> <td style="display: none; text-align: left"> </td><td id="xdx_491_20260430__20260430__spac--OverAllotmentOptionAxis__custom--WithOverAllotmentMember__spac--RedemptionLevelAxis__spac--RedemptionAt100PercentOfMaximumMember_zBDBp2Uiegtk" style="display: none; text-align: right"> </td><td style="display: none; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="38" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">As of April 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">25% Redemption</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">50% Redemption</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">75% Redemption</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">100% Redemption</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Without Over- allotment </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">With Over- allotment </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Without Over- allotment </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">With Over- allotment </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Without Over- allotment </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">With Over- allotment </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Without Over- allotment </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">With Over- allotment </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Without Over- allotment </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">With Over- allotment </td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Numerator</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_espac--NetTangibleBookValue_zQpYElTrUMNf" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 40%; text-align: left">Net tangible book deficit before this offering</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 3%; text-align: right">(109,800</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 3%; text-align: right">(109,800</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 3%; text-align: right">(109,800</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 3%; text-align: right">(109,800</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 3%; text-align: right">(109,800</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 3%; text-align: right">(109,800</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 3%; text-align: right">(109,800</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 3%; text-align: right">(109,800</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 3%; text-align: right">(109,800</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 3%; text-align: right">(109,800</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_408_espac--NetTangibleBookValueAdjusted_hspac--DilutionSourceAxis__custom--NetProceedsFromThisOfferingAndTheSaleOfThePrivatePlacementSharesMember_z215OIdSREWj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Plus: Net proceeds from this offering and the sale of the private placement shares(1)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">76,725,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">88,143,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">76,725,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">88,143,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">76,725,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">88,143,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">76,725,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">88,143,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">76,725,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">88,143,750</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_espac--NetTangibleBookValueAdjusted_hspac--DilutionSourceAxis__custom--OfferingCostsPaidInAdvanceExcludedFromTangibleBookValueMember_zhlHaBxYLxMi" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Plus: Offering costs paid in advance, excluded from tangible book value</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">85,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">85,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">85,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">85,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">85,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">85,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">85,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">85,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">85,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">85,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_espac--NetTangibleBookValueAdjusted_hspac--DilutionSourceAxis__custom--DeferredUnderwritingFeesMember_ztGY3aexBWl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Less: Deferred underwriting fees(2)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,806,250</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,377,188</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,854,688</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,282,891</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,903,125</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,188,594</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(951,563</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,094,297</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_espac--NetTangibleBookValueAdjusted_hspac--DilutionSourceAxis__spac--OverallotmentLiabilityMember_zIG5YwoyA02c" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Less: Over-allotment liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_espac--NetTangibleBookValueAdjusted_hspac--DilutionSourceAxis__custom--ProceedsFromFounderSharesMember_zcVNeTgft8tj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Plus: Proceeds from founder shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_espac--NetTangibleBookValueAdjusted_hspac--DilutionSourceAxis__custom--AmountPaidForRedemptionsMember_zVpHx1l02sC2" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Less: Amount paid for redemptions (3) </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(18,750,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(21,562,500</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(37,500,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(43,125,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(56,250,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(64,687,500</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(75,000,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(86,250,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_40C_espac--NetTangibleBookValueAdjusted_zuafiPNK1ZX8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Total</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">72,918,950</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">83,766,762</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">55,120,512</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">63,298,559</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">37,322,075</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">42,830,356</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">19,523,637</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">22,362,153</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">1,725,200</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">1,893,950</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_espac--NumberOfSharesUsedAdjustment_hspac--DilutionSourceAxis__custom--OrdinarySharesOutstandingPriorToThisOfferingMember_zcE9vaNuDCc6" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Ordinary shares outstanding prior to this offering</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,354,167</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,354,167</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,354,167</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,354,167</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,354,167</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,354,167</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,354,167</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,354,167</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,354,167</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,354,167</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_espac--NumberOfSharesUsedAdjustment_hspac--DilutionSourceAxis__custom--OrdinarySharesForfeitedIfOverallotmentIsNotExercisedMember_zrxvradmCcUj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Less: Ordinary shares forfeited if over-allotment is not exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(437,500</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(437,500</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(437,500</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(437,500</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(437,500</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_espac--NumberOfSharesUsedAdjustment_hspac--DilutionSourceAxis__custom--OrdinarySharesOfferedAndSaleOfPrivatePlacementSharesMember_zdwOJasyftL8" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Ordinary shares offered and sale of private placement shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,814,250</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,970,188</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,814,250</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,970,188</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,814,250</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,970,188</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,814,250</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,970,188</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,814,250</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,970,188</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_espac--NumberOfSharesUsedAdjustment_hspac--DilutionSourceAxis__custom--SharesSubjectToRedemptionMember_zNtQlaphoMWl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Less: shares subject to redemption</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,875,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,156,250</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,750,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,312,500</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5,625,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(6,468,750</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(7,500,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(8,625,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_40C_espac--NumberOfSharesUsedAdjustment_zTxndIOKHTA4" style="vertical-align: bottom; background-color: White"> <td>Total</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,730,917</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,324,355</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,855,917</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,168,105</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,980,917</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,011,855</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,105,917</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,855,605</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,230,917</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,699,355</td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">(1)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Expenses applied against gross proceeds include offering expenses of approximately $480,000. See “Use of Proceeds.”</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">(2)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Represents the value of 45-day over-allotment option from the date of this prospectus granted to the underwriters to purchase an aggregate of up to 1,125,000 additional ordinary shares at the initial public offering price less the underwriting commissions. The underwriters’ over-allotment option is deemed to be a freestanding financial instrument indexed on the shares subject to redemption and will be accounted for as a liability pursuant to ASC 480 if not fully exercised at the time of the initial public offering. The table above assumes that the option has either been fully exercised or has expired with no exercise to purchase additional shares, thus the value of over-allotment liability in both scenario is $0.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(3)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">If we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, our initial shareholders, advisors or their affiliates may purchase shares in privately negotiated transactions or in the open market either prior to or following the completion of our initial business combination. In the event of any such purchases of our shares prior to the completion of our initial business combination, the number of ordinary shares subject to redemption will be reduced by the amount of any such purchases, increasing the pro forma net tangible book value per share. See “Proposed Business - Permitted Purchases and other Transactions with Respect to Our Securities.”</td></tr> </table> 2916667 25000 0.0086 314250 3142500 10.00 7500000 75000000 10.00 10730917 78167500 -109800 -109800 -109800 -109800 -109800 -109800 -109800 -109800 -109800 -109800 76725000 88143750 76725000 88143750 76725000 88143750 76725000 88143750 76725000 88143750 85000 85000 85000 85000 85000 85000 85000 85000 85000 85000 -3806250 -4377188 -2854688 -3282891 -1903125 -2188594 -951563 -1094297 25000 25000 25000 25000 25000 25000 25000 25000 25000 25000 -18750000 -21562500 -37500000 -43125000 -56250000 -64687500 -75000000 -86250000 72918950 83766762 55120512 63298559 37322075 42830356 19523637 22362153 1725200 1893950 3354167 3354167 3354167 3354167 3354167 3354167 3354167 3354167 3354167 3354167 -437500 -437500 -437500 -437500 -437500 7814250 8970188 7814250 8970188 7814250 8970188 7814250 8970188 7814250 8970188 -1875000 -2156250 -3750000 -4312500 -5625000 -6468750 -7500000 -8625000 10730917 12324355 8855917 10168105 6980917 8011855 5105917 5855605 3230917 3699355 Moreover, we may need to obtain additional financing to complete our initial business combination, either because the transaction requires more cash than is available from the proceeds held in our trust account or because we become obligated to redeem a significant number of our public shares upon completion of the business combination, in which case we may issue additional securities or incur debt in connection with such business combination. If we raise additional funds through equity or convertible debt issuances, our public shareholders may suffer significant dilution and these securities could have rights that rank senior to our public shares. If we raise additional funds through the incurrence of indebtedness, such indebtedness will have rights that are senior to our equity securities and could contain covenants that restrict our operations. Further, as described above, due to the anti-dilution rights of our founder shares, our public shareholders may incur material dilution. In addition, we intend to target businesses with enterprise values that are greater than we could acquire with the net proceeds of this offering and the sale of the private placement shares, and, as a result, if the cash portion of the purchase price exceeds the amount available from the trust account, net of amounts needed to satisfy any redemptions by our public shareholders, we may be required to seek additional financing to complete such proposed initial business combination. We may also obtain financing prior to the closing of our initial business combination to fund our working capital needs and transaction costs in connection with our search for and completion of our initial business combination. There is no limitation on our ability to raise funds through the issuance of equity or equity-linked securities or through loans, advances or other indebtedness in connection with our initial business combination, including pursuant to forward purchase agreements or backstop agreements we may enter into following consummation of this offering. Subject to compliance with applicable securities laws, we would only complete such financing simultaneously with the completion of our initial business combination. If we are unable to complete our initial business combination because we do not have sufficient funds available to us, we will be forced to liquidate the trust account. In addition, following our initial business combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations. 2916667 25000 314250 3142500 10000 Reimbursement for any out-of-pocket expenses related to identifying, investigating and completing an initial business combination Assumes no exercise of the over-allotment option and the full surrender and forfeiture of 437,500 shares that are subject to surrender and forfeiture by certain of our initial shareholders depending on the extent to which the underwriters’ over-allotment option is exercised. If we increase or decrease the size of this offering, we will effect a share dividend or share contribution back to capital or other appropriate mechanism, as applicable, with respect to the founder shares immediately prior to the consummation of this offering in such amount as to maintain the number of founder shares at 28% of our issued and outstanding ordinary shares upon the consummation of this offering (not including the private placement shares and assuming the sponsor does not purchase shares in this offering), with any such change in the number of founder shares to be allocated to our sponsor. <p id="xdx_89B_espac--SpacSponsorAndAffiliatesInformationRestrictionsOnSaleOfSpacSecuritiesTableTextBlock_dU_z3cilJIBtLlj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Pursuant to a letter agreement to be entered with us, each of our initial shareholders, including our sponsor, and our directors and officers, has agreed to certain restrictions on such party’s ability to transfer, assign or sell the founder shares and private placement shares to unaffiliated parties, as summarized in the table below. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center">Subject Securities</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 27%; text-align: center">Expiration Date</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 22%">Natural Persons and Entities Subject to Restrictions</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 27%; text-align: center">Exceptions to Transfer Restrictions </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">Founder shares</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpKDkpIFJlc3RyaWN0aW9ucyBvbiBTZWxsaW5nIFNlY3VyaXRpZXMA" id="xdx_90E_espac--SpacSponsorDescriptionOfExpirationDatesOfRestrictionsTextBlock_c20260526__20260526__spac--SecurityClassAxis__spac--FounderSharesMember_ztpyT3CbjWN7">The earlier of (A) 180 days after the completion of our initial business combination or earlier if, subsequent to our initial business combination, the closing price of the ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub- divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day at least 90 days after our initial business combination and (B) the date following the completion of our initial business combination on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our shareholders having the right to exchange their ordinary shares for cash, securities or other property.</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Crestone Strategic Capital Limited Hongtao Sun Wenxi He Oscar Sanz Paris Lincoln Teo Choong Han Aleksandar Georgiev Keratsinov <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpKDkpIFJlc3RyaWN0aW9ucyBvbiBTZWxsaW5nIFNlY3VyaXRpZXMA" id="xdx_907_espac--SpacSponsorPersonsAndEntitiesSubjectToRestrictions_c20260526__20260526__spac--SecurityClassAxis__spac--FounderSharesMember_zWwYiu0OyHi3" style="display: none">Crestone Strategic Capital Limited, Hongtao Sun, Wenxi He, Oscar Sanz Paris, Lincoln Teo Choong Han, Aleksandar Georgiev Keratsinov</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpKDkpIFJlc3RyaWN0aW9ucyBvbiBTZWxsaW5nIFNlY3VyaXRpZXMA" id="xdx_90A_espac--SpacSponsorDescriptionOfExceptionsToRestrictionsTextBlock_c20260526__20260526__spac--SecurityClassAxis__spac--FounderSharesMember_zHL3TXbokxei">Transfers permitted (a) to the Company’s officers or directors, any affiliates or family members of any of the Company’s officers or directors, any members or partners of the Sponsor or their affiliates, any affiliates of the Sponsor, or any employees of such affiliates; (b) in the case of an individual, by gift to a member of such individual’s immediate family or to a trust, the beneficiary of which is a member of such individual’s immediate family, an affiliate of such individual or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of such individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with any forward purchase agreement or similar arrangement or in connection with the consummation of an initial Business Combination at prices no greater than the price at which the securities were originally purchased; (f) in the event of the Company’s liquidation prior to the Company’s completion of an initial Business Combination; (g) by virtue of the laws of the British Virgin Islands or the Sponsor’s organizational documents upon liquidation or dissolution of the Sponsor; (h) to the Company for no value for cancellation in connection with the consummation of an initial Business Combination; (i) in the event of the Company’s liquidation prior to the consummation of an initial Business Combination; or (j) in the event of the Company’s completion of a liquidation, merger, capital share exchange or other similar transaction which results in all of the Company’s shareholders having the right to exchange their Ordinary Shares for cash, securities or other property subsequent to the Company’s completion of an initial Business Combination; provided, however, that in the case of clauses (a) through (e) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and by the same agreements entered into by our sponsor with respect to such securities (including provisions relating to voting, the trust account and liquidation distributions described elsewhere in this prospectus).</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">Private placement shares </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpKDkpIFJlc3RyaWN0aW9ucyBvbiBTZWxsaW5nIFNlY3VyaXRpZXMA" id="xdx_90C_espac--SpacSponsorDescriptionOfExpirationDatesOfRestrictionsTextBlock_c20260526__20260526__spac--SecurityClassAxis__custom--PrivatePlacementSharesMember_zhPKldZrhZ7e">Until 30 days after the completion of our initial business combination.</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpKDkpIFJlc3RyaWN0aW9ucyBvbiBTZWxsaW5nIFNlY3VyaXRpZXMA" id="xdx_90B_espac--SpacSponsorPersonsAndEntitiesSubjectToRestrictions_c20260526__20260526__spac--SecurityClassAxis__custom--PrivatePlacementSharesMember_zbrqzbNog3Z7">Crestone Strategic Capital Limited</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpKDkpIFJlc3RyaWN0aW9ucyBvbiBTZWxsaW5nIFNlY3VyaXRpZXMA" id="xdx_90C_espac--SpacSponsorDescriptionOfExceptionsToRestrictionsTextBlock_c20260526__20260526__spac--SecurityClassAxis__custom--PrivatePlacementSharesMember_zVPdywTR0Mr9">Same as above</td></tr> </table> The earlier of (A) 180 days after the completion of our initial business combination or earlier if, subsequent to our initial business combination, the closing price of the ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub- divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day at least 90 days after our initial business combination and (B) the date following the completion of our initial business combination on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our shareholders having the right to exchange their ordinary shares for cash, securities or other property. Crestone Strategic Capital Limited, Hongtao Sun, Wenxi He, Oscar Sanz Paris, Lincoln Teo Choong Han, Aleksandar Georgiev Keratsinov Transfers permitted (a) to the Company’s officers or directors, any affiliates or family members of any of the Company’s officers or directors, any members or partners of the Sponsor or their affiliates, any affiliates of the Sponsor, or any employees of such affiliates; (b) in the case of an individual, by gift to a member of such individual’s immediate family or to a trust, the beneficiary of which is a member of such individual’s immediate family, an affiliate of such individual or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of such individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with any forward purchase agreement or similar arrangement or in connection with the consummation of an initial Business Combination at prices no greater than the price at which the securities were originally purchased; (f) in the event of the Company’s liquidation prior to the Company’s completion of an initial Business Combination; (g) by virtue of the laws of the British Virgin Islands or the Sponsor’s organizational documents upon liquidation or dissolution of the Sponsor; (h) to the Company for no value for cancellation in connection with the consummation of an initial Business Combination; (i) in the event of the Company’s liquidation prior to the consummation of an initial Business Combination; or (j) in the event of the Company’s completion of a liquidation, merger, capital share exchange or other similar transaction which results in all of the Company’s shareholders having the right to exchange their Ordinary Shares for cash, securities or other property subsequent to the Company’s completion of an initial Business Combination; provided, however, that in the case of clauses (a) through (e) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and by the same agreements entered into by our sponsor with respect to such securities (including provisions relating to voting, the trust account and liquidation distributions described elsewhere in this prospectus). Until 30 days after the completion of our initial business combination. Crestone Strategic Capital Limited Same as above We, our sponsor and our executive officers and directors have agreed that, for a period of 180 days from the date of this prospectus, we and they will not, without the prior written consent of the Representative, offer, sell, contract to sell, pledge, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, any ordinary shares or any other securities convertible into, or exercisable or exchangeable for, any ordinary shares, founder shares or warrants, subject to certain exceptions. The Representative in its sole discretion may release any of the securities subject to these lock-up agreements at any time without notice, other than in the case of the officers and directors, which shall be with notice. Our initial shareholders, including our sponsor, the unaffiliated founder share transferees and our officers and directors, are also subject to separate transfer restrictions on their founder shares and private placement shares pursuant to the letter agreement described herein. REDEMPTION RIGHTS FOR PUBLIC SHAREHOLDERS UPON COMPLETION OF OUR INITIAL BUSINESS COMBINATION We will provide our public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of our initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account calculated as of two business days prior to the consummation of the initial business combination, including interest (net of taxes paid or payable, if any and up to US$100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding public shares, subject to the limitations described herein. Our public shareholders will be permitted to redeem their shares regardless of whether they abstain, vote for, vote against, or vote at all with respect to the proposed business combination. At the completion of our initial business combination, we will be required to purchase any public shares properly delivered for redemption and not withdrawn. The amount in the trust account is initially anticipated to be $10.15 per public share. The per share amount we will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions we will pay to the underwriter. The redemption rights will include the requirement that a beneficial holder must identify itself in order to validly redeem its shares. Our initial shareholders, including our sponsor, the unaffiliated founder share transferees and our directors and officers, have entered into a letter agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to any shares held by them in connection with the completion of our initial business combination. MANNER OF CONDUCTING REDEMPTIONS We will provide our public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of our initial business combination either (1) in connection with a general meeting called to approve the business combination or (2) by means of a tender offer. The decision as to whether we will seek shareholder approval of a proposed business combination or conduct a tender offer will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would require us to seek shareholder approval under the Companies Act or stock exchange listing requirement. Asset acquisitions and share purchases would not typically require shareholder approval while direct mergers with our company (other than with a 90% subsidiary of ours) and any transactions where we issue more than 20% of our issued and outstanding ordinary shares or seek to amend our amended and restated memorandum and articles of association would typically require shareholder approval. If a shareholder vote is not required and we choose not to seek shareholder approval for business or other reasons, we intend to conduct redemptions without a shareholder vote pursuant to the tender offer rules of the SEC unless shareholder approval is required by applicable law or stock exchange listing requirement. If shareholder approval of the transaction is required by applicable law or stock exchange listing requirement, or we decide to obtain shareholder approval for business or other reasons, we will, pursuant to our amended and restated memorandum and articles of association: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">conduct the redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, which regulates the solicitation of proxies, and not pursuant to the tender offer rules; and</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">file proxy materials with the SEC.</td></tr> </table> We expect that a final proxy statement would be mailed to public shareholders at least twenty days prior to the shareholder vote. However, we expect that a preliminary proxy statement would be made available to such shareholders in advance of such time, providing additional notice of redemption if we conduct redemptions in conjunction with a proxy solicitation. Although we are not required to do so, we intend to comply with the substantive and procedural requirements of Regulation 14A in connection with any shareholder vote even if we are not able to maintain our Nasdaq listing or Exchange Act registration. If we seek shareholder approval, we will complete our initial business combination only if we obtain the approval of an ordinary resolution under Cayman Islands law, which requires the affirmative vote of a simple majority of the voting rights held by such members as, being entitled to do so, vote in person or by proxy at a general meeting of the company. A quorum for such general meeting will consist of the holders present in person or by proxy of shares of the company representing one-third of the issued and outstanding shares entitled to vote at such general meeting. Our initial shareholders will count towards this quorum and have agreed to vote any shares held by them in favor of our initial business combination. Assuming only the minimum number of shares representing a quorum are voted, the over-allotment option is not exercised and the initial shareholders do not purchase any shares in this offering or shares in the after-market, we would need public shareholders holding at least 346,055 public shares, or approximately 4.61% of the 7,500,000 public shares sold in this offering, to be present in order to establish a quorum. Our initial shareholders are expected to beneficially own an aggregate of 3,230,917 shares (consisting of 2,916,667 founder shares and 314,250 private placement shares) and have agreed to vote all of their shares in favor of our initial business combination. As a result, once a quorum is present, the votes controlled by our initial shareholders would be sufficient to approve our initial business combination, and we may be able to complete our initial business combination even if none of our public shareholders vote in favor of the initial business combination. These quorum and voting thresholds and agreements may make it more likely that we will consummate our initial business combination. Each public shareholder may elect to redeem its public shares irrespective of whether it votes for, votes against, or votes at all with respect to the proposed business combination. Redemptions of our public shares may be subject to a net tangible asset test or cash requirement pursuant to an agreement relating to our initial business combination. For example, the proposed business combination may require: (1) cash consideration to be paid to the target or its owners; (2) cash to be transferred to the target for working capital or other general corporate purposes; or (3) the retention of cash to satisfy other conditions in accordance with the terms of the proposed business combination. In the event the aggregate cash consideration we would be required to pay for all public shares that are validly submitted for redemption plus any amount required to satisfy cash conditions pursuant to the terms of the proposed business combination exceed the aggregate amount of cash available to us, we will not complete the business combination or redeem any shares, and all ordinary shares submitted for redemption will be returned to the holders thereof, and we instead may search for an alternate business combination (including, potentially, with the same target). If, however, a shareholder vote is not required and we decide not to hold a shareholder vote for business or other reasons, we will, pursuant to our amended and restated memorandum and articles of association: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">conduct the redemptions pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, which regulate issuer tender offers; and</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">file tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same financial and other information about the initial business combination and the redemption rights as is required under Regulation 14A of the Exchange Act, which regulates the solicitation of proxies.</td></tr> </table> Upon the public announcement of our initial business combination, if we elect to conduct redemptions pursuant to the tender offer rules, we and our sponsor will terminate any plan established in accordance with Rule 10b5-1 to purchase ordinary shares in the open market, in order to comply with Rule 14e-5 under the Exchange Act. In the event we conduct redemptions pursuant to the tender offer rules, our offer to redeem will remain open for at least 20 business days, in accordance with Rule 14e-1(a) under the Exchange Act, and we will not be permitted to complete our initial business combination until the expiration of the tender offer period. Furthermore, redemptions of our public shares may be subject to a net tangible asset test or cash requirement pursuant to an agreement relating to our initial business combination. Consequently, if accepting all properly submitted redemption requests would cause our net tangible assets to be less than the amount necessary to satisfy a closing condition as described above, we would not proceed with such redemption and the related business combination and may instead search for an alternate business combination (including, potentially, with the same target). CONFLICTS OF INTERESTOur sponsor currently holds 3,354,167 ordinary shares (which were purchased for $25,000, or approximately $0.0075 per share), up to 437,500 of which are subject to surrender and forfeiture by certain of our sponsor depending on the extent to which the underwriters’ over-allotment option is exercised. Because our sponsor acquired the founder shares at a nominal price, our public shareholders will incur an immediate and substantial dilution upon the closing of this offering. If we do not complete an initial business combination within the completion window, the proceeds from the sale of the private placement shares will be included in the liquidating distribution to our public shareholders and the private placement shares and founder shares will be worthless.If we increase or decrease the size of this offering, we will effect a share dividend or share contribution back to capital or other appropriate mechanism, as applicable, with respect to the founder shares immediately prior to the consummation of this offering in such amount as to maintain the number of founder shares at 28% of our issued and outstanding ordinary shares upon the consummation of this offering (not including the private placement shares and assuming the sponsor does not purchase shares in this offering), with any such change in the number of founder shares to be allocated to our sponsor. Also, each of our officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such officers and directors was included by a target business as a condition to any agreement with respect to our initial business combination. As a result, the fiduciary duties, conflicts of interest or contractual obligations of our officers or directors could materially affect our ability to complete our initial business combination. Our initial shareholders are not prohibited from sponsoring, investing in or otherwise becoming involved with, any other blank check companies (including special purpose acquisition companies similar to our company), including in connection with their initial business combinations, prior to us completing our initial business combination. Potential investors should also be aware of the following potential conflicts of interest: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">None of our officers or directors is required to commit his or her full time to our affairs and, accordingly, may have conflicts of interest in allocating his or her time among various business activities.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">In the course of their other business activities, our officers and directors may become aware of investment and business opportunities which may be appropriate for presentation to us as well as the other entities with which they are affiliated. Our management may have conflicts of interest in determining to which entity a particular business opportunity should be presented.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Our initial shareholders purchased founder shares prior to the date of this prospectus and the sponsor will purchase the private placement shares in transactions that will close simultaneously with the closing of this offering. Our initial shareholders have agreed to waive their right to liquidating distributions with respect to its founder shares if we fail to consummate our initial business combination within the required time period. However, if our initial shareholders acquire public shares in or after this offering, they will be entitled to receive liquidating distributions with respect to such public shares if we fail to consummate our initial business combination within the required time period. If we do not complete our initial business combination within such applicable time period, the proceeds of the sale of the private placement shares will be used to fund the redemption of our public shares, and the private placement shares will expire worthless.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Our officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such officers and directors was included by a target business as a condition to any agreement with respect to our initial business combination.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Certain of our initial shareholders, directors and officers presently has, and any of them in the future may have additional, fiduciary or contractual obligations to other entities pursuant to which such officer or director is or will be required to present a business combination opportunity to such entity. As a result, our officers or directors may present a potential target to our competitor that would have been presented to us or devote time to our affairs which may have a negative impact on our ability to complete our initial business combination.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Our officers and directors may in the future become affiliated with entities, including other blank check companies, engaged in business activities similar to those intended to be conducted by our company.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Repayment of loans which may be made by our sponsor or an affiliate of our sponsor or certain of our officers and directors to finance transaction costs in connection with an intended initial business combination. Up to $1,500,000 of such loans may be converted into private placement shares of the post-business combination entity at a price of $10.00 per private share at the option of the applicable lender. Such working capital shares would be identical to the private placement shares. Except for the foregoing, the terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. These financial interests of our sponsor, executive officers and directors may influence their motivation in identifying and selecting a target business combination and completing an initial business combination.</td></tr> </table> Under Cayman Islands law, directors and officers owe the following fiduciary duties: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">(i)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">duty to act in good faith in what the director or officer believes to be in the best interests of the company as a whole;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">(ii)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">duty to exercise powers for the purposes for which those powers were conferred and not for a collateral purpose;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">(iii)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">directors should not improperly fetter the exercise of future discretion;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">(iv)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">duty not to put themselves in a position in which there is a conflict between their duty to the company and their personal interests; and</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">(v)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">duty to exercise independent judgment.</td></tr> </table> In addition to the above, directors also owe a duty of care which is not fiduciary in nature. This duty has been defined as a requirement to act as a reasonably diligent person having both the general knowledge, skill and experience that may reasonably be expected of a person carrying out the same functions as are carried out by that director in relation to the company and the general knowledge skill and experience which that director has. Below is a table summarizing the entities to which our officers, directors and director nominees currently have fiduciary duties or contractual obligations which will take priority over us. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%">Individual</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 2%"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 31%; text-align: center">Entity</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 2%"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: center">Entity’s Business</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 2%"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center">Affiliation/Title</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">Hongtao Sun</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif">KX Power Limited</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Renewable energy & power generation asset </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Chief Technology Officer</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">Wenxi He</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif">KX Power Limited</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Renewable energy & power generation asset </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Chief Investment Officer</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Metal Sky Star Acquisition Corporation</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Special Purpose Acquisition Company</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Chief Executive Officer, Chief Financial Officer, and Chairwoman</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif">DT Cloud Acquisition Corporation</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Special Purpose Acquisition Company</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Independent Director</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">Oscar Sanz Paris</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif">CQUR Bank</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Banking</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Deputy CEO & Chief Commercial Officer </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">Lincoln Teo Choong Han </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Intelligence Wise (iWise)</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Corporate data exchange </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Founder</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif">ZERO13</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Renewable Energy</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Managing Director </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">Aleksandar Georgiev Keratsinov</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif">ContourGlobal</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Renewable Energy</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Senior Project Manager </td></tr> </table> Assumes no exercise of the over-allotment option and the full surrender and forfeiture of 437,500 shares that are subject to surrender and forfeiture by certain of our initial shareholders depending on the extent to which the underwriters’ over-allotment option is exercised. If we increase or decrease the size of this offering, we will effect a share dividend or share contribution back to capital or other appropriate mechanism, as applicable, with respect to the founder shares immediately prior to the consummation of this offering in such amount as to maintain the number of founder shares at 28% of our issued and outstanding ordinary shares upon the consummation of this offering (not including the private placement shares and assuming the sponsor does not purchase shares in this offering), with any such change in the number of founder shares to be allocated to our sponsor. Assumes the full surrender and forfeiture of 437,500 founder shares and no exercise of the underwriters’ over-allotment option. Expenses applied against gross proceeds include offering expenses of approximately $480,000. See “Use of Proceeds.” Represents the value of 45-day over-allotment option from the date of this prospectus granted to the underwriters to purchase an aggregate of up to 1,125,000 additional ordinary shares at the initial public offering price less the underwriting commissions. The underwriters’ over-allotment option is deemed to be a freestanding financial instrument indexed on the shares subject to redemption and will be accounted for as a liability pursuant to ASC 480 if not fully exercised at the time of the initial public offering. The table above assumes that the option has either been fully exercised or has expired with no exercise to purchase additional shares, thus the value of over-allotment liability in both scenario is $0. If we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, our initial shareholders, advisors or their affiliates may purchase shares in privately negotiated transactions or in the open market either prior to or following the completion of our initial business combination. In the event of any such purchases of our shares prior to the completion of our initial business combination, the number of ordinary shares subject to redemption will be reduced by the amount of any such purchases, increasing the pro forma net tangible book value per share. See “Proposed Business - Permitted Purchases and other Transactions with Respect to Our Securities.”